Abouzid, M.; Kosicka-Noworzyń, K.; Karaźniewicz-Łada, M.; Rao, P.; Modi, N.; Xie, Y.L.; Heysell, S.K.; Główka, A.; Kagan, L.
Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. Molecules 2024, 29, 337.
https://doi.org/10.3390/molecules29020337
AMA Style
Abouzid M, Kosicka-Noworzyń K, Karaźniewicz-Łada M, Rao P, Modi N, Xie YL, Heysell SK, Główka A, Kagan L.
Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. Molecules. 2024; 29(2):337.
https://doi.org/10.3390/molecules29020337
Chicago/Turabian Style
Abouzid, Mohamed, Katarzyna Kosicka-Noworzyń, Marta Karaźniewicz-Łada, Prakruti Rao, Nisha Modi, Yingda L. Xie, Scott K. Heysell, Anna Główka, and Leonid Kagan.
2024. "Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine" Molecules 29, no. 2: 337.
https://doi.org/10.3390/molecules29020337
APA Style
Abouzid, M., Kosicka-Noworzyń, K., Karaźniewicz-Łada, M., Rao, P., Modi, N., Xie, Y. L., Heysell, S. K., Główka, A., & Kagan, L.
(2024). Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine. Molecules, 29(2), 337.
https://doi.org/10.3390/molecules29020337